DIA 2022 Global Annual Meeting

Home/Conferences | Posted 16/05/2022

Collaboration Without Boundaries
19-23 June 2022
Chicago, IL, USA

27th Medicines for Europe Annual Conference 2022

Home/Conferences | Posted 01/04/2022

27th Annual Conference 2022
29 June1 July 2022
Dolce Sitges Hotel, Sitges (Barcelona), Spain

Medicines for Europe 16th Legal Affairs Conference 2022

Home/Conferences | Posted 22/04/2022

Medicines for Europe 16th Legal Affairs Conference 2022
29 June 2022 (with welcome dinner session on 28 June 2022)
Dolce Sitges Hotel, Sitges (Barcelona), Spain

The 16th Medicines for Europe Legal Affairs Conference will take place in Sitges (Barcelona) on 28‒29 June 2022!

DIA Biosimilars USA 2022

Home/Conferences | Posted 18/03/2022

Collaborate for Progress at DIA’s Biosimilars Conference in Arlington, VA – 20–21 September 2022

AAM GRx+Biosims 2022

Home/Conferences | Posted 01/04/2022

GRx+Biosims 2022
7−9 November 2022
Bethesda North Marriott Hotel and Conference Center
North Bethesda, Maryland, USA

Microbiological control symposium: consensus on readiness of new methods emerges

Home/Conferences | Posted 27/10/2017

A symposium on microbiology in the pharmaceutical sector was the opportunity for the European Directorate for the Quality of Medicines & HealthCare (EDQM) to gather feedback from users of the European Pharmacopoeia on alternative testing methods for microbiological control and sterilisation processes. The event, which took place in Strasbourg on 10−11 October 2017, was attended by a wide range of experts in the pharmaceutical and microbiological fields who reviewed the latest trends and innovations in the field of microbiology, in addition to pharmacopoeial approaches and related regulatory requirements.

European Pharmacopoeia prepares for the future through exchange with stakeholders

Home/Conferences | Posted 14/10/2016

To mark the publication of the 9th edition of the European Pharmacopoeia (Ph. Eur.), the EDQM (European Directorate for the Quality of Medicines) organized a large international conference in Tallinn, Estonia, which brought together representatives of European and international regulatory authorities, the World Health Organization (WHO), pharmacopoeias from different continents as well as industry and associations from Europe and beyond. Participants came from 41 different countries, including Brazil, Canada, India, Japan, South Africa, Taiwan and USA.

French generics association promotes biosimilars

Home/Conferences | Posted 17/10/2014

French generics association GEMME held its first symposium on the challenges and opportunities associated with biosimilars in France on 3 October 2014.

Topics presented at the 16th IGPA conference on generics

Home/Conferences | Posted 17/01/2014

Topics presented at the 16th Annual IGPA Conference, held in Brussels, Belgium, 9–11 December 2013, showed that despite differences in the pharmaceutical market in different countries most appreciate the value of generics. In most cases this is driven by cost reduction.

EGA pushes for increased focus on generics and biosimilars

Home/Conferences | Posted 21/06/2013

EGA President Ms Gudbjorg Edda Eggertsdottir, speaking at the European Generic medicines Association’s (EGA’s) conferences in London, UK (11th EGA International Symposium on Biosimilar Medicines) and in Athens, Greece (19th EGA Annual Conference); stressed the importance of keeping generics and biosimilars manufacturers within Europe, thus ensuring that high quality manufacturing jobs and know-how remains in Europe. This would benefit society and patients and increase the competitiveness and innovative capacity of the pharmaceutical industry in Europe.